Wednesday, 24 February 201608:00 | Registration & Coffee | 08:55 | Opening Welcome from the Conference Chairman – Karl Tryggvason, Professor, Duke-NUS Graduate Medical School & Karolinska Institutet, Stockholm | | Session Chair: Karl Tryggvason Professor, Duke-NUS Graduate Medical School & Karolinska Institutet, Stockholm |
| | 09:00 | | 10:00 | Using functional genomics to understand neural degeneration Lawrence Stanton, Associate Director, Genome Institute of Singapore, Singapore
| 10:30 | Coffee Break and Networking in Exhibition Area | | Session Chair: Roy Calne, Professor Emeritus of Surgery, University of Cambridge, United Kingdom |
| | 11:15 | Therapeutic Potential of Human Neural Crest-Derived Stem Cells Darius Widera, Lecturer, University Of Reading, United Kingdom
| 11:45 | Differentiation of human embryonic stem cells to endothelial progenitor cells on laminins in defined and xeno-free systems Mien Nguyen, Research Fellow, Duke-NUS Medical School, Singapore
| 12:15 | Cellular modelling of trisomy 21 as an approach to understand Alzheimer’s disease Dean Nizetic, Professor of Molecular Medicine, Nanyang Technological University, Singapore
| 12:45 | Lunch, Poster Session and Networking in Exhibit Hall | | Session Chair: Roy Calne, Professor Emeritus of Surgery, University of Cambridge, United Kingdom |
| | 14:15 | | 15:15 | Aerosol-based stem cell delivery as a new strategy for treatment of lung diseases Badrul Hisham Yahaya, Senior Lecturer/Principal Investigator/Head, Stem Cell and Gene Therapy Group, Universiti Sains Malaysia, Malaysia
| 15:45 | Coffee Break and Networking in Exhibition Area | | Session Chair: Roy Calne, Professor Emeritus of Surgery, University of Cambridge, United Kingdom |
| | 16:30 | A phase II clinical trial in patients with Buerger’s disease using bone marrow derived, pooled, allogeneic mesenchymal stromal cells Anoop CH, Assistant Director – Clinical Research, Stempeutics Research Pvt. Ltd., India
| 17:00 | Clinical Application of Osteoblastic Cell-based Therapy in Spinal Fusion Wendy Sonnet, Clinical Study Manager, Bone Therapeutics, Belgium Sabrina Ena, Preclinical Research Supervisor, Bone Therapeutics, Belgium
| 17:30 | Cutting Edge Aspects in Stem Cell and PRP injections in an office Setting Joseph Purita, Medical Director of Stem Cell Centers of America, Institute Of Regenerative and Molecular Orthopedics, United States of America
| 18:00 | End of Day One |
Thursday, 25 February 201608:00 | Registration & Coffee | | Session Chair: Lawrence Stanton, Associate Director, Genome Institute of Singapore, Singapore |
| | 09:00 | | 10:00 | Adipose Stem Cell Extraction: Bridging the Gap Teck Sin Lim, Founder, Adigenics, Singapore Pamela Mok, Project Manager, Adigenics, Singapore
| 10:30 | Coffee Break and Networking in Exhibition Area | | Session Chair: Lawrence Stanton, Associate Director, Genome Institute of Singapore, Singapore |
| | 11:15 | Mesenchymal stem cells for cartilage regeneration Zheng Yang, Principal Investigator, NUS Tissue Engineering Program, National University of Singapore, Singapore
| 11:45 | Ex-Vivo Expansion Of Human Cardiac Biopsy-Derived Stem Cells In Physico-Chemically Defined Nutrient Media Silvana Bardelli, Group Leader - Technology Transfer and Product Development, Swiss Institute for Regenerative Medicine, Switzerland
| 12:15 | Molecular Signatures of Adipose-derived Stem Cells: Potential for Metabolic Reprogramming Shigeki Sugii, Group Leader/Assistant Professor, Singapore Bioimaging Consortium/Duke NUS Graduate Medical School, Singapore
| 12:45 | Lunch Break and Networking in Exhibition Area | | Session Chair: Shigeki Sugii, Group Leader/Assistant Professor, Singapore Bioimaging Consortium/Duke NUS Graduate Medical School, Singapore |
| | 14:15 | Need for reference standards in cell therapy Vivek Tanavde, Principal Investigator, Bioinformatics Institute, Singapore
| 15:00 | Genome editing-mediated cell transplantations: Clinical, ethical and legal issues Tetsuya Ishii, Professor, Hokkaido University, Japan
| 15:45 | Coffee Break and Networking in Exhibition Area | 16:30 | PANEL DISCUSSION - Regulatory Landscape, Ethical Considerations & Clinical Challenges in Stem Cell Translation
| 17:30 | Close of Conference |
|